• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Repligen Corporation (RGEN)

    -NasdaqGS
    21.55 Up 0.63(3.01%) Dec 18, 4:00PM EST
    |After Hours : 21.55 0.00 (0.00%) Dec 18, 4:36PM EST
    Add to Portfolio
    Prev Close:20.92
    Open:21.02
    Bid:7.66 x 100
    Ask:N/A
    1y Target Est:25.33
    Beta:1.93
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:20.89 - 21.74
    52wk Range:11.70 - 26.75
    Volume:360,911
    Avg Vol (3m):369,780
    Market Cap:705.14M
    P/E (ttm):59.86
    EPS (ttm):0.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RGENUp 3.01%705.14M
    BIOUp 1.68%3.50B

    Key Statistics

    Forward P/E (1 yr):63.38
    P/S (ttm):10.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.28
    Quarterly EPS Est (Dec-14) :0.03
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback